Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS opened at $0.24 on Friday. Pieris Pharmaceuticals has a 12-month low of $0.16 and a 12-month high […]

Leave a Reply

Your email address will not be published.

Previous post New Relic (NYSE:NEWR) Research Coverage Started at StockNews.com
Next post StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)